3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Withdrawn
1
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Head & Neck
2
Conditions
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Thyroid Nodule
1
Disease
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
4
Surgical Procedures, Operative
3
Iodine-131
3
Iodine-124
3
Biopsy
3
selpercatinib
2
lenvatinib
2
Watchful Waiting
2
Thyrotropin Alfa
2
Therapeutics
2
Nivolumab
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Cetuximab
2
Biopsy, Fine-Needle
2
trastuzumab deruxtecan
1
trametinib
1
sintilimab
1
sacituzumab govitecan
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
gallium Ga 68 dotatate
1
fludarabine phosphate
1
defactinib
1
dabrafenib
1
cemiplimab
1
brodalumab
1
binimetinib
1
anlotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Thyroid Neoplasms
×
Biopsy, Fine-Needle
×
Clear all
NCT07419932
2026-02-19
NeoLATC
Fujian Medical University
Recruiting
120 enrolled
NCT06984991
2026-02-03
FNA inadequacy
Assiut University
Phase NA
Recruiting
160 enrolled